A role for the polymorphism at position 247 of the β2-glycoprotein I gene in the generation of anti-β2-glycoprotein I antibodies in the antiphospholipid syndrome

被引:0
|
作者
Hirose, N
Williams, R
Alberts, AR
Furie, RA
Chartash, EK
Jain, RI
Sison, C
Lahita, RG
Merrill, JT
Cucurull, E
Gharavi, AE
Sammaritano, LR
Salmon, J
Hashimoto, S
Sawada, T
Chu, CC
Gregersen, PK
Chiorazzi, N
机构
[1] N Shore Univ Hosp, Manhasset, NY 11030 USA
[2] NYU, Sch Med, Manhasset, NY USA
[3] St Lukes Roosevelt Hosp, New York, NY USA
[4] Louisiana State Univ, Med Ctr, New Orleans, LA USA
[5] Morehouse Sch Med, Atlanta, GA 30310 USA
[6] Hosp Special Surg, New York, NY 10021 USA
[7] Tokyo Womens Med Coll, Tokyo 162, Japan
[8] Univ Tokyo, Sch Med, Tokyo 113, Japan
来源
ARTHRITIS AND RHEUMATISM | 1999年 / 42卷 / 08期
关键词
D O I
10.1002/1529-0131(199908)42:8<1655::AID-ANR14>3.0.CO;2-B
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine the frequencies at which either a valine or leucine occurs at position 247 in the beta(2)-glycoprotein I (beta(2)GPI) gene of normal individuals of the Caucasian, African American, and Asian ethnic groups and to compare these data with those in patients with the antiphospholipid syndrome (APS), with and without anti-beta(2)GPI antibodies. Methods. The DNA segment containing the position-247 polymorphism was amplified by semi-nested polymerase chain reaction, and the polymorphism was detected by restriction endonuclease digestion. DNA samples from 370 healthy controls of different racial backgrounds were analyzed, and the results were compared with those from 149 APS patients (66 primary; 83 secondary), Allele and genotype frequencies were compared using Fisher's exact test. When significant differences were detected, pairwise comparisons were made using Fisher's exact test,vith a Bonferroni adjustment. Results. Allele and genotype expression was significantly different (P < 0.0001 for both) among the 3 races, with the V allele and the VV genotype occurring most often among Caucasians, less among African Americans, and least among Asians. Conversely, the V allele and the VV genotype were found more frequently among Asian APS patients than among controls (P = 0.0028 and P = 0.0023, respectively). No significant differences in allele or genotype frequencies were seen in comparisons of the Caucasian or the African American patients with appropriate controls, The differences in allele and genotype frequencies seen in the Asian APS patients were restricted to the anti-beta(2)GPI-positive patients (P = 0.0018 and P = 0.0005, respectively). Conclusion. In Asian patients with APS, expression of a V at position 247, especially in the homozygous state, is significantly associated with the presence of anti-beta(2)GPI antibodies and, therefore, can be viewed as a major risk factor in this ethnic group (odds ratio 9.19 and 16.33, respectively).
引用
收藏
页码:1655 / 1661
页数:7
相关论文
共 50 条
  • [1] Valine/Leucine247 polymorphism of β2-glycoprotein I in patients with antiphospholipid syndrome:: lack of association with anti-β2-glycoprotein I antibodies
    Swadzba, J
    Sanak, M
    Iwaniec, T
    Dziedzina, S
    Musial, J
    LUPUS, 2006, 15 (04) : 218 - 222
  • [2] Anti-β2-glycoprotein I antibodies and the antiphospholipid syndrome
    Li, Z
    Krilis, SA
    AUTOIMMUNITY REVIEWS, 2003, 2 (05) : 229 - 234
  • [3] Valine/valine genotype at position 247 of the β2-glycoprotein I gene in Mexican patients with primary antiphospholipid syndrome -: Association with anti-β2-glycoprotein I antibodies
    Prieto, GA
    Cabral, AR
    Zapata-Zuñiga, M
    Simón, AJ
    Villa, AR
    Alarcón-Segovia, D
    Cabiedes, J
    ARTHRITIS AND RHEUMATISM, 2003, 48 (02): : 471 - 474
  • [4] Correlation between β2-glycoprotein I valine/leucine247 polymorphism and anti-β2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome
    Atsumi, T
    Tsutsumi, A
    Amengual, O
    Khamashta, MA
    Hughes, GRV
    Miyoshi, Y
    Ichikawa, K
    Koike, T
    RHEUMATOLOGY, 1999, 38 (08) : 721 - 723
  • [5] Significance of valine/leucine247 polymorphism of β2-glycoprotein I in antiphospholipid syndrome -: Increased reactivity of anti-β2-glycoprotein I autoantibodies to the valine247 γ2-glycoprotein I variant
    Yasuda, S
    Atsumi, T
    Matsuura, E
    Kaihara, K
    Yamamoto, D
    Ichikawa, K
    Koike, T
    ARTHRITIS AND RHEUMATISM, 2005, 52 (01): : 212 - 218
  • [6] Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome
    Cucnik, S.
    Kveder, T.
    Artenjak, A.
    Gallova, Z. Ulcova
    Swadzba, J.
    Musial, J.
    Iwaniec, T.
    Stojanovich, L.
    Alessandri, C.
    Valesini, G.
    Avcin, T.
    Tervaert, J. W. Cohen
    Rozman, B.
    Bozic, B.
    LUPUS, 2012, 21 (07) : 764 - 765
  • [7] Anti-β2-glycoprotein I antibodies
    Willis, Rohan
    Pierangeli, Silvia S.
    YEAR IN IMMUNOLOGY, 2013, 1285 : 44 - 58
  • [8] Anti-β2-glycoprotein I antibodies
    Tsutsumi, A
    Ichikawa, K
    Matsuura, E
    Koike, T
    LUPUS, 1998, 7 : S98 - S102
  • [9] Pathogenic role of anti-β2-glycoprotein I antibodies in antiphospholipid associated fetal loss:: characterisation of β2-glycoprotein I binding to trophoblast cells and functional effects of anti-β2-glycoprotein I antibodies in vitro
    Di Simone, N
    Raschi, E
    Testoni, C
    Castellani, R
    D'Asta, M
    Shi, T
    Krilis, SA
    Caruso, A
    Meroni, PL
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (03) : 462 - 467
  • [10] β2-glycoprotein I and anti-β2-glycoprotein I antibodies:: Where are we now?
    Inanç, M
    Radway-Bright, EL
    Isenberg, DA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (12): : 1247 - 1257